Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Centre Hospitalier Régional Universitaire (CHRU) de Nancy, a leading academic hospital in the Grand Est region of France, announced a 10-year agreement to implement Philips' IntelliSpace Enterprise Imaging Solution, including Illumeo with adaptive intelligence.
MedTech Europe released today a call to action towards digital health interoperability, endorsing the European Commission's Electronic Health Record Exchange Format released on 6 February 2019. The statement also called on European national and regional health authorities, payers and procurers, and adjacent industries, to do the same.
Allscripts (NASDAQ: MDRX) announced its patient and consumer engagement platform, FollowMyHealth, as a platform for existing Microsoft HealthVault users to transition and share their health data with family, friends or their home care team when required. FollowMyHealth offers a streamlined option for users to export their existing data and continue tracking their health online or through its mobile apps on iOS and Android.
| Location: | Eindhoven, Netherlands |
| Job Type: | Full-Time |
| Employer: | Philips |
Oxford Health NHS Foundation Trust has introduced a new observation protocol for checking the safety of patients with severe mental health conditions at night, after a formal evaluation of technology from Oxehealth.
18 - 21 November 2019, Düsseldorf, Germany.
Advanced therapies are a major part of new Innovative Medicines Initiative (IMI) Calls for proposals. The two advanced therapies topics aim to accelerate research into advanced therapies for rare diseases, and support the development of engineered T cells to fight cancer. Other topics in the Calls address artificial intelligence; the need for reliable, relevant health information; and ways of incorporating patients' views and experiences into healthcare and cancer clinical trials.
QUIBIM is helping to advance knowledge of the most lethal pediatric tumors through EU-funded project PRIMAGE, which exploits precision information from medical imaging to establish tumor prognosis, and expected treatment response using radiomics, imaging biomarkers and artificial intelligence (AI).